Durban 2000 to Toronto 2006: The evolving challenges in implementing AIDS treatment in Africa

AIDS

Volumn 20, Issue 15, 2006, Pages

  Karim, Salim S Abdool ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CANADA; EPIDEMIC; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTORY OF MEDICINE; HUMAN; INFECTION PREVENTION; INTERNATIONAL COOPERATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIAL DISCRIMINATION; SOUTH AFRICA; SUSTAINABLE DEVELOPMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; ANTI-RETROVIRAL AGENTS; CONGRESSES; DRUG COSTS; HIV INFECTIONS; HUMANS;

EID: 33748915810     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000247110.51338.73     Document Type: Article

References (17)

1. Abdool Karim S, Abdool Karim Q. Breaking the silence, one year later: reflections on the Durban Conference. AIDS Clin Care 2001; 13:63-65.
2. WHO Reproductive Health Library. RHL informing best practice in repoductive health. Geneva: WHO; 2005.
3. van Oosterhout JJ, Bodasing N, Kumwenda JJ, Nyirenda C, Mallewa J, Cleary PR, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre. Malawi. Trop Med Int Health 2005; 10:464-470.
4. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004; 20:1053-1056.
5. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, DRB. Adherence to HIV antiretroviral therapy in HIVR Ugandan patients purchasing therapy. Int J STD AIDS 2005; 16:38-41.
6. WHO. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach 2003 Revision. Geneva: WHO; 2003.
7. The Durban Declaration. Nature 2000. 406:15-16.
8. TAC website. South African public health facilities offering antiretroviral treatment. http://www.tac.org.za/arvsites.html. Updated May 2006.
9. Treatment Action Campaign. Focus of Health workers. Equal Treatment: newsletter of the treatment action group 2005: 2-15.
10. Weiner R, Mitchell G, Price M. Wits medical graduates: where are they now? South African J Sci 1998; 94:59-63.
11. De Cock KM, Johnson AM. From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ 1998; 316:290-293.
12. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000; 356:113-121.
13. Badri M, Maartens G, Mandalia S, Bekker L-G, Penrod JR, Platt RW, et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLOS Med 2005; 3:1-9.
14. Cameron E. Forum Lecture: 'Normalising testing - normalising AIDS'. University of KwaZulu-Natal, Durban, 2006. Available from: www.ukzn.ac.za/ccs/ files/LouwRonaldMay06.pdf.
15. Parker R, Aggleton Peter. HIV and AIDS-related stigma and discrimination. Soc Sci Med 2003; 57:13-24.
16. Valdiserri R. Stigma: an impediment to public health. Am J Public Health 2002; 92:341-342.
17. Global HIV Prevention Working Group. HIV prvention in the era of expanded treatment access. www.gatesfoundation.org. Gates Foundation; June 2004.